Von Gierke’s disease – case report
Keywords:
Von Gierke’s disease, epatomegaly, dyslipidemia, hyperuricemia, anemia, hepatic adenomaAbstract
Von Gierke’s (DG) disease, or type I glycogenesis, is an autosomal recessive disorder characterized by an impaired activity of
glucose-6-phosphatase enzyme. It is associated with delayed
growth, recurrent infections, hyperuricemia, dyslipidemia, anemia,
renal dysfunction and hepatic adenomas. Treatment consists of
maintaining appropriate physiological glucose levels. CASE REPORT: 24-year old female patient diagnosed with DG in her second
year of life as a result of an investigation due to delayed growth
and hepatomegaly. A fractionated diet based on carbohydrates
was initiated. Cognitive disability has developed, dyslipidemia and
hyperuricemia were diagnosed at age of 8 and 10 years of age,
respectively. As an adult, she was referred to an Internal Medicine
department. It was detected hypothyroidism and hepatic nodules,
with the histological study revealing adenomas. At age of 21, she
developed anemia as a consequence of menorrhagia. At age of
22, arterial hypertension was noticed. Nephrotic proteinuria was
observed in the last examination. The authors present this case
because describes a condition rarely seen in an Internal Medicine ward or outpatient clinic that warrants continuous clinical
monitoring due to the risk of metabolic, cardiovascular, hepatic
and renal complications.
Downloads
References
Bali D, Chen Y., Goldstein J. Glycogen Storage Disease Type I. Gene Reviews 2010.
Antunes J, Fontes F. Disfunção do complexo glicose-6-fostase. Arquivos de Medicina 2009; 23: 109-117.
Reis C, Penna F, Oliveira M et al. Glycogenosis type I. Jornal de Pediatria 1999; 75: 227-236.
Froissart R, Piraud M., Boudjemline A et al. Glucose-6-phosphatase deficiency, Orphanet Journal of Rare Diseases 2011; 6: 27.
Moses S.; Historical highlights and unsolved problems in glycogen storage disease type. European Journal of Pediatrics 2002, 161: S2-9.
Melis D., Pivonello R, Della R et al. Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. European Journal of Pediatrics 2007, 150: 300-305.
UpToDate, versão 19.2
Minarich L, Kirpich A, Fiske L, Weinstein D. Bone mineral density in glycogen storage disease type Ia and Ib. Genetics in Medicine 2012.
Correia C, Bhattacharya K, Lee P et al. Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. The American Journal of Clinical Nutrition 2008; 88:1272- 1276.
Koeberl D, Kishnani P, Chen Y. Glycogen storage disease types I and II: treatment updates. Journal of Inherited Metabolic Disease 2007; 30:159-164
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna